Profile

MolecuLight DX is a handheld, point of care wound imaging device that delivers real time fluorescence visualization of elevated bacterial loads and precise digital wound measurement. FDA cleared, it enables objective, on site detection of infection, guiding targeted debridement, treatment decisions, and optimized antibiotic use. Backed by peer reviewed evidence showing workflow changes in over 50% of cases, strong cost savings, and clinical impact, it empowers clinicians to improve healing outcomes and reduce complications.


Event details

Date: October 5 - 8, 2025

Event contact

Patricia Cosgrove
Area Director
USA: Life Sciences

Participants

14 in total